Alan Hochberg is a Scientific Enablement Leader at Roche in Basel, Switzerland, responsible for developing strategic innovations in pharmacovigilance. He was formerly Vice President of Research at ProSanos, where he developed and evaluated signal-detection algorithms and learning models of disease progression. He has worked in bioinformatics and biomedical engineering for the past 41 years, at DuPont, Hologic, and J&J. He holds several patents on medical devices and data analysis methods. He received his B.S. degree in Engineering from Princeton University.